Abstract | SCOPE: A number of findings suggest that zero-calorie d- allulose, also known as d-psicose, has beneficial effects on obesity-related metabolic disturbances. However, it is unclear whether d- allulose can normalize the metabolic status of diet-induced obesity without having an impact on the energy density. We investigated whether 5% d- allulose supplementation in a high fat diet(HFD) could normalize body fat in a diet-induced obesity animal model under isocaloric pair-fed conditions. METHODS AND RESULTS: Mice were fed an HFD with or without various sugar substitutes ( d-glucose, d- fructose, erytritol, or d- allulose, n = 10 per group) for 16 wk. Body weight and fat-pad mass in the d- allulose group were dramatically lowered to that of the normal group with a simultaneous decrease in plasma leptin and resistin concentrations. d- allulose lowered plasma and hepatic lipids while elevating fecal lipids with a decrease in mRNA expression of CD36, ApoB48, FATP4, in the small intestine in mice. In the liver, activities of both fatty acid synthase and β-oxidation were downregulated by d- allulose to that of the normal group; however, in WAT, fatty acid synthase was decreased while β-oxidation activity was enhanced. CONCLUSION: Taken together, our findings suggest that 5% dietary d- allulose led to the normalization of the metabolic status of diet-induced obesity by altering lipid-regulating enzyme activities and their gene-expression level along with fecal lipids.
|
Authors | Youngji Han, Hye Jin Han, Ae-Hyang Kim, Ji-Young Choi, Su-Jung Cho, Yong Bok Park, Un Ju Jung, Myung-Sook Choi |
Journal | Molecular nutrition & food research
(Mol Nutr Food Res)
Vol. 60
Issue 7
Pg. 1695-706
(07 2016)
ISSN: 1613-4133 [Electronic] Germany |
PMID | 26920079
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. |
Chemical References |
- Apolipoprotein B-48
- Blood Glucose
- CD36 Antigens
- Fatty Acid Transport Proteins
- Leptin
- Resistin
- Slc27a4 protein, mouse
- Sweetening Agents
- psicose
- Fructose
- Glucose
|
Topics |
- Adiposity
(drug effects)
- Animals
- Apolipoprotein B-48
(genetics, metabolism)
- Blood Glucose
(metabolism)
- Body Weight
(drug effects)
- CD36 Antigens
(genetics, metabolism)
- Diet, High-Fat
- Dietary Supplements
- Fatty Acid Transport Proteins
(genetics, metabolism)
- Fructose
(administration & dosage)
- Gene Expression Regulation
- Glucose
(administration & dosage)
- Leptin
(blood)
- Lipid Metabolism
(drug effects)
- Liver
(drug effects, metabolism)
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Obese
- Obesity
(drug therapy, etiology)
- Resistin
(blood)
- Sweetening Agents
(administration & dosage)
|